Medicare Considers Coverage of Genetic Prostate Cancer Test

Overtreatment of prostate cancer represents one of the most significant issues in men’s health today. As a result of the limited information available from a biopsy, more than 90 percent of low-risk patients undergo immediate treatment, such as prostate removal or radiation, despite having less than a 3 percent chance of their low-risk disease progressing to become … Read More

Prostate Cancer: Can You Watch and Wait?

When a man is diagnosed with prostate cancer, the first question that comes to mind may be, “How soon can I be treated?” But treatment isn’t always the answer, especially for low-risk cases. That’s why the Oncotype DX Prostate Cancer Test made headlines when it was announced last month. The test is designed to determine … Read More